相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Randomized Double-Blind Placebo-Controlled Study of Olanzapine for Chemotherapy-Related Anorexia in Patients With Locally Advanced or Metastatic Gastric, Hepatopancreaticobiliary, and Lung Cancer
Lakshmi Sandhya et al.
JOURNAL OF CLINICAL ONCOLOGY (2023)
EDA2R-NIK signalling promotes muscle atrophy linked to cancer cachexia
Sevval Nur Bilgic et al.
NATURE (2023)
Cancer-associated cachexia - understanding the tumour macroenvironment and microenvironment to improve management
Josep M. Argiles et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2023)
Pilot clinical trial of macimorelin to assess safety and efficacy in patients with cancer cachexia
Megan Herodes et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2023)
Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia
Jawed Akhtar Siddiqui et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2022)
Efficacy of Curcumin on Treating Cancer Anorexia-Cachexia Syndrome in Locally or Advanced Head and Neck Cancer: A Double-Blind, Placebo-Controlled Randomised Phase IIa Trial (CurChexia)
Tawasapon Thambamroong et al.
JOURNAL OF NUTRITION AND METABOLISM (2022)
A Systematic Review and Meta-Analysis of the Clinical Use of Megestrol Acetate for Cancer-Related Anorexia/Cachexia
Yu Liang Lim et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Cancer cachexia as a multiorgan failure: Reconstruction of the crime scene
Michele Ferrara et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)
Targeting cancer cachexia: Molecular mechanisms and clinical study
Yong-Fei Wang et al.
MEDCOMM (2022)
Understanding the molecular basis of anorexia and tissue wasting in cancer cachexia
Eunbyul Yeom et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2022)
Mirtazapine in Cancer-Associated Anorexia and Cachexia: A Double-Blind Placebo-Controlled Randomized Trial
Catherine N. Hunter et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2021)
Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines
J. Arends et al.
ESMO OPEN (2021)
The Redox Balance: A Target for Interventions Against Muscle Wasting in Cancer Cachexia?
Fabio Penna et al.
ANTIOXIDANTS & REDOX SIGNALING (2020)
Management of Cancer Cachexia: Attempting to Develop New Pharmacological Agents for New Effective Therapeutic Options
Gioacchino P. Marceca et al.
FRONTIERS IN ONCOLOGY (2020)
Effect of a leucine-rich supplement in combination with nutrition and physical exercise in advanced cancer patients: A randomized controlled intervention trial
Lena J. Storck et al.
CLINICAL NUTRITION (2020)
Management of Cancer Cachexia: ASCO Guideline
Eric J. Roeland et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Olanzapine for the Treatment of Advanced Cancer-Related Chronic Nausea and/or Vomiting A Randomized Pilot Trial
Rudolph M. Navari et al.
JAMA ONCOLOGY (2020)
Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment
A. Fabi et al.
ANNALS OF ONCOLOGY (2020)
Orphan disease status of cancer cachexia in the USA and in the European Union: a systematic review
Markus S. Anker et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2019)
First-in-Human Phase I Study of the Activin A Inhibitor, STM 434, in Patients with Granulosa Cell Ovarian Cancer and Other Advanced Solid Tumors
Jessica J. Tao et al.
CLINICAL CANCER RESEARCH (2019)
A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in advanced gastrointestinal cancer patients with cancer cachexia
Satoshi Hamauchi et al.
CANCER (2019)
Prokinetics and ghrelin for the management of cancer cachexia syndrome
Jimi S. Malik et al.
ANNALS OF PALLIATIVE MEDICINE (2019)
The Effects of Dosage-Controlled Cannabis Capsules on Cancer-Related Cachexia and Anorexia Syndrome in Advanced Cancer Patients: Pilot Study
Gil Bar-Sela et al.
INTEGRATIVE CANCER THERAPIES (2019)
Tumor Necrosis Factor-Alpha: Role in Development of Insulin Resistance and Pathogenesis of Type 2 Diabetes Mellitus
Muhammad Sajid Hamid Akash et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Systematic review and meta-analysis of the evidence for oral nutritional intervention on nutritional and clinical outcomes during chemo(radio)therapy: current evidence and guidance for design of future trials
M. A. E. de van der Schueren et al.
ANNALS OF ONCOLOGY (2018)
Randomized double-blind clinical trial of combined treatment with megestrol acetate plus celecoxib versus megestrol acetate alone in cachexia-anorexia syndrome induced by GI cancers
Bizhan Kouchaki et al.
SUPPORTIVE CARE IN CANCER (2018)
The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: a randomized, double-blind clinical trial
Jenny G. Turcott et al.
SUPPORTIVE CARE IN CANCER (2018)
A randomized trial of adjunct testosterone for cancer-related muscle loss in men and women
Traver J. Wright et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2018)
Cancer-associated cachexia
Vickie E. Baracos et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial
Talia Golan et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2018)
Inter-tissue communication in cancer cachexia
Josep M. Argiles et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Anamorelin (ONO-7643) for the Treatment of Patients With Non-Small Cell Lung Cancer and Cachexia: Results From a Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Japanese Patients (ONO-7643-04)
Nobuyuki Katakami et al.
CANCER (2018)
Hedgehog signaling in bone regulates whole-body energy metabolism through a bone-adipose endocrine relay mediated by PTHrP and adiponectin
Xu Zhang et al.
CELL DEATH AND DIFFERENTIATION (2017)
A systematic review on the role of vitamins, minerals, proteins, and other supplements for the treatment of cachexia in cancer: a European Palliative Care Research Centre cachexia project
Mochamat et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2017)
Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial
Srdan Verstovsek et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study
Tamas Hickish et al.
LANCET ONCOLOGY (2017)
Anamorelin for advanced non-small-cell lung cancer with cachexia: Systematic review and meta-analysis
Kenichi Nishie et al.
LUNG CANCER (2017)
Pearls of optimizing nutrition and physical performance of older adults undergoing cancer therapy
Antonio Vigano et al.
JOURNAL OF GERIATRIC ONCOLOGY (2017)
A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer
Tora S. Solheim et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2017)
Association between cachexia, chemotherapy and outcomes in older cancer patients: A systematic review
Philippe Caillet et al.
CLINICAL NUTRITION (2017)
ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia
D. Currow et al.
ANNALS OF ONCOLOGY (2017)
Exercise for people with cancer: a systematic review
R. Segal et al.
CURRENT ONCOLOGY (2017)
ESPEN guidelines on definitions and terminology of clinical nutrition
T. Cederholm et al.
CLINICAL NUTRITION (2017)
Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials
Jennifer S. Temel et al.
LANCET ONCOLOGY (2016)
Lipolytic and thermogenic depletion of adipose tissue in cancer cachexia
Maria Tsoli et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2016)
Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials)
Jeffrey Crawford et al.
CURRENT ONCOLOGY REPORTS (2016)
Espindolol for the treatment and prevention of cachexia in patients with stage III/IV non-small cell lung cancer or colorectal cancer: a randomized, double-blind, placebo-controlled, international multicentre phase II study (the ACT-ONE trial)
Andrew J. Stewart Coats et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2016)
Understanding cachexia as a cancer metabolism syndrome
P. E. Porporato
ONCOGENESIS (2016)
Xilonix, a novel true human antibody targeting the inflammatory cytokine interleukin-1 alpha, in non-small cell lung cancer
David S. Hong et al.
INVESTIGATIONAL NEW DRUGS (2015)
Myostatin: Expanding horizons
Mridula Sharma et al.
IUBMB LIFE (2015)
Muscle wasting in disease: molecular mechanisms and promising therapies
Shenhav Cohen et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
The Consumption of Omega-3 Polyunsaturated Fatty Acids Improves Clinical Outcomes and Prognosis in Pancreatic Cancer Patients: A Systematic Evaluation
Ying-Jie Ma et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2015)
Nutritional Advice in Older Patients at Risk of Malnutrition during Treatment for Chemotherapy: A Two-Year Randomized Controlled Trial
Isabelle Bourdel-Marchasson et al.
PLOS ONE (2014)
Psychosocial impact of cancer cachexia
Jane B. Hopkinson
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2014)
Non-steroidal anti-inflammatory treatment in cancer cachexia: A systematic literature review
Tora S. Solheim et al.
ACTA ONCOLOGICA (2013)
Clinical evaluation and optimal management of cancer cachexia
Albert Tuca et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
Control of food intake and muscle wasting in cachexia
Marie Amitani et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
Effects of Melatonin on Appetite and Other Symptoms in Patients With Advanced Cancer and Cachexia: A Double-Blind Placebo-Controlled Trial
Egidio Del Fabbro et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Understanding the mechanisms and treatment options in cancer cachexia
Kenneth Fearon et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Cancer cachexia: impact, mechanisms and emerging treatments
Vanessa C. Vaughan et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2013)
Clinical development of ghrelin axis-derived molecules for cancer cachexia treatment
Sumbul Ali et al.
CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE (2013)
Megestrol acetate for treatment of anorexia-cachexia syndrome
Vicente Ruiz Garcia et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
Effects of ghrelin administration during chemotherapy with advanced esophageal cancer patients
Yuichiro Hiura et al.
CANCER (2012)
Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways
Kenneth C. H. Fearon et al.
CELL METABOLISM (2012)
Randomized phase III clinical trial of a combined treatment with carnitine plus celecoxib ± megestrol acetate for patients with cancer-related anorexia/cachexia syndrome
Clelia Madeddu et al.
CLINICAL NUTRITION (2012)
Inflammation in cancer cachexia: To resolve or not to resolve (is that the question?)
Marilia Seelaender et al.
CLINICAL NUTRITION (2012)
A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: Evaluating the impact on metabolic and inflammatory profiles and quality of life
Antonio Maccio et al.
GYNECOLOGIC ONCOLOGY (2012)
L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN) - a randomized multicentre trial
Matthias Kraft et al.
NUTRITION JOURNAL (2012)
A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer
Trevor J. Bayliss et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2011)
Definition and classification of cancer cachexia: an international consensus
Kenneth Fearon et al.
LANCET ONCOLOGY (2011)
Phase II Trial of Mirtazapine for Cancer-Related Cachexia and Anorexia
Rachel P. Riechelmann et al.
AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE (2010)
Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) cachexia-anorexia in chronic wasting diseases and nutrition in geriatrics
M. Muscaritoli et al.
CLINICAL NUTRITION (2010)
Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia
Giovanni Mantovani et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2010)
A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9)
Aminah Jatoi et al.
LUNG CANCER (2010)
MUSCLE DISORDERS Preventing wastage
Man Tsuey Tse
NATURE REVIEWS DRUG DISCOVERY (2010)
Treatment of cancer-related anorexia with olanzapine and megestrol acetate: a randomized trial
Rudolph M. Navari et al.
SUPPORTIVE CARE IN CANCER (2010)
Ghrelin for cachexia
Takashi Akamizu et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2010)
Defining and Classifying Cancer Cachexia: A Proposal by the SCRINIO Working Group
Federico Bozzetti et al.
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2009)
Cachexia: A new definition
William J. Evans et al.
CLINICAL NUTRITION (2008)
Results of a pilot study of the effects of celecoxib on cancer cachexia in patients with cancer of the head, neck, and gastrointestinal tract
Victor Lai et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2008)
The E3 ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle
Brian A. Clarke et al.
CELL METABOLISM (2007)
A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome - Results from NOOC1 from the North Central Cancer Treatment Group
Aminah Jatoi et al.
CANCER (2007)
Association between megestrol acetate treatment and symptomatic adrenal insufficiency with hypogonadism in male patients with cancer
Rony Dev et al.
CANCER (2007)
Ectopic expression of myostatin induces atrophy of adult skeletal muscle by decreasing muscle gene expression
Anne-Cecile Durieux et al.
ENDOCRINOLOGY (2007)
Mechanism of increased lipolysis in cancer cachexia
Thorhallur Agustsson et al.
CANCER RESEARCH (2007)
Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia
A. Dewey et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2007)
Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis
KC Fearon et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2006)
Systematic review of the treatment of cancer-associated anorexia and weight loss
T Yavuzsen et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial
JN Gordon et al.
GUT (2005)
Effects of recombinant erythropoietin in palliative treatment of unselected cancer patients
E Lindholm et al.
CLINICAL CANCER RESEARCH (2004)
Ghrelin: An orexigenic and somatotrophic signal from the stomach
A Inui
NATURE REVIEWS NEUROSCIENCE (2001)
Fatal hepatorenal failure associated with hydrazine sulfate
MI Hainer et al.
ANNALS OF INTERNAL MEDICINE (2000)
A double-blind, crossover study of controlled-release metoclopramide and placebo for the chronic nausea and dyspepsia of advanced cancer
E Bruera et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2000)
分享论文
